Andy Scharenberg, MD, co-founder and CEO of Umoja Biopharma, and assignment team members CRB and Umoja opened the occasion with a tour and assignment review. Participants included government and economic progress representatives, partners and members of the CRB assignment team, and management of Umoja Biopharma.
“It has been a privilege to work with Umoja to perform a task in aid of science and transformative treatments to treat cancerous tumors. Working intensively with Umoja demonstrates their commitment to sustainability, diversity, equity, inclusion, creativity and the timely delivery of the “These commitments and goals have unified our team members and allowed us to assist in the evolution of technology. We are revered that Umoja has entrusted us with the realization of this assignment,” said Colton Koncak, Colorado market team leader at CRB.
Watch the content to download multimedia: https://www. prnewswire. com/news-releases/crb-joins-umoja-biopharma-to-celebrate-the-beginning-of-construction-at-development-and-man manufacturing-site – 301365355. html
SOURCE CRB